UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia | Leukemia
Venetoclax plus intensive induction chemotherapy safe for fit, older patients with AML
Survival of de novo acute myeloid leukemia at MD Anderson (1970-2017)... | Download Scientific Diagram
Decitabine shows comparable OS to standard induction chemotherapy and better safety in patients with AML
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Secondary vs de novo acute myeloid leukemia
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst - ScienceDirect
Diagnosis and treatment of therapy-related acute myeloid leukemia - ScienceDirect
Overall survival time in de novo AML and in t-AML. t-AML,... | Download Scientific Diagram
Frontiers | Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities | Haematologica
Common mutations in de novo and secondary AML. A number of clonal blood... | Download Scientific Diagram
Secondary acute myeloid leukemia
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults | Blood Cancer Journal
What is AML? | MDS Foundation
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
Acute Myeloid Leukemia | Oncohema Key
Recurrent mutation groups in de novo AML. Genes recurrently mutated in... | Download Scientific Diagram
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics | Leukemia
Key Topic Videos | MYLOTARG®▽(gemtuzumab ozogamicin) | PfizerPro UK
Biology of secondary leukemia
Mutational variation in de-novo and secondary acute myeloid Leukemia.... | Download Scientific Diagram
How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube
